TY - JOUR
T1 - Trigger-Associated Clinical Implications and Outcomes in Takotsubo Syndrome
T2 - Results From the Multicenter GEIST Registry
AU - Pätz, Toni
AU - Santoro, Francesco
AU - Cetera, Rosa
AU - Ragnatela, Ilaria
AU - El-Battrawy, Ibrahim
AU - Mezger, Matthias
AU - Rawish, Elias
AU - Andrés-Villarreal, Mireia
AU - Almendro-Delia, Manuel
AU - Martinez-Sellés, Manuel
AU - Uribarri, Aitor
AU - Pérez-Castellanos, Alberto
AU - Guerra, Federico
AU - Novo, Giuseppina
AU - Mariano, Enrica
AU - Musumeci, Maria Beatrice
AU - Arcari, Luca
AU - Cacciotti, Luca
AU - Montisci, Roberta
AU - Akin, Ibrahim
AU - Thiele, Holger
AU - Brunetti, Natale Daniele
AU - Vedia, Oscar
AU - Núñez-Gil, Ivan J.
AU - Eitel, Ingo
AU - Stiermaier, Thomas
N1 - Publisher Copyright:
© 2023 The Authors.
PY - 2023
Y1 - 2023
N2 - BACKGROUND: Takotsubo syndrome is usually triggered by a stressful event. The type of trigger seems to influence the outcome and should therefore be considered separately. METHODS AND RESULTS: Patients included in the GEIST (German-Italian-Spanish Takotsubo) registry were categorized accord-ing to physical trigger (PT), emotional trigger (ET), and no trigger (NT) of Takotsubo syndrome. Clinical characteristics as well as outcome predictors were analyzed. Overall, 2482 patients were included. ET was detected in 910 patients (36.7%), PT in 885 patients (34.4%), and NT was observed in 717 patients (28.9%). Compared with patients with PT or NT, patients with ET were younger, less frequently men, and had a lower prevalence of comorbidities. Adverse in-hospital events (NT: 18.8% versus PT: 27.1% versus ET: 12.1%, P<0.001) and long-term mortality rates (NT: 14.4% versus PT: 21.6% versus ET: 8.5%, P<0.001) were significantly lower in patients with ET. Increasing age (P<0.001), male sex (P=0.007), diabetes (P<0.001), malignancy (P=0.002), and a neurological disorder (P<0.001) were associated with a higher risk of long-term mortality, while chest pain (P=0.035) and treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker (P=0.027) were confirmed as independent predictors for a lower risk of long-term mortality. CONCLUSIONS: Patients with ET have better clinical conditions and a lower mortality rate. Increasing age, male sex, malignancy, a neurological disorder, chest pain, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, and diabetes were confirmed as predictors of long-term mortality.
AB - BACKGROUND: Takotsubo syndrome is usually triggered by a stressful event. The type of trigger seems to influence the outcome and should therefore be considered separately. METHODS AND RESULTS: Patients included in the GEIST (German-Italian-Spanish Takotsubo) registry were categorized accord-ing to physical trigger (PT), emotional trigger (ET), and no trigger (NT) of Takotsubo syndrome. Clinical characteristics as well as outcome predictors were analyzed. Overall, 2482 patients were included. ET was detected in 910 patients (36.7%), PT in 885 patients (34.4%), and NT was observed in 717 patients (28.9%). Compared with patients with PT or NT, patients with ET were younger, less frequently men, and had a lower prevalence of comorbidities. Adverse in-hospital events (NT: 18.8% versus PT: 27.1% versus ET: 12.1%, P<0.001) and long-term mortality rates (NT: 14.4% versus PT: 21.6% versus ET: 8.5%, P<0.001) were significantly lower in patients with ET. Increasing age (P<0.001), male sex (P=0.007), diabetes (P<0.001), malignancy (P=0.002), and a neurological disorder (P<0.001) were associated with a higher risk of long-term mortality, while chest pain (P=0.035) and treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker (P=0.027) were confirmed as independent predictors for a lower risk of long-term mortality. CONCLUSIONS: Patients with ET have better clinical conditions and a lower mortality rate. Increasing age, male sex, malignancy, a neurological disorder, chest pain, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, and diabetes were confirmed as predictors of long-term mortality.
UR - http://www.scopus.com/inward/record.url?scp=85165222684&partnerID=8YFLogxK
U2 - 10.1161/JAHA.122.028511
DO - 10.1161/JAHA.122.028511
M3 - Journal articles
C2 - 37421264
AN - SCOPUS:85165222684
SN - 2047-9980
VL - 12
JO - Journal of the American Heart Association
JF - Journal of the American Heart Association
IS - 14
M1 - e028511
ER -